National and Kapodistrian University of Athens
Η σημασία της έκφρασης της L-DOPA αποκαρβοξυλάσης (DDC) στον καρκίνο του προστάτη
Abstract
dc:descriptionPURPOSE: The role of L-DOPA decarboxylase (DDC) expression in patients with prostate cancer (CaP), and its potential utility as biomarker in the differential diagnosis between the CaP and the benign prostatic hyperplasia (BPH) has been extensively studied. Furthermore, its potential role in the prognostication of CaP has been evaluated. MATERIALS AND METHODS: For the quantitative determination of DDC mRNA transcripts, a particularly sensitive quantitative real-time polymerase chain reaction (qRT-PCR) method has been developed. The samples of prostate tissues from 57 patients with BPH and 70 patients with CaP, who previously had been operated on, were studied and the results were compared with those of RT-PCR from the same samples. RESULTS: DDC expression, at mRNA level, was observed in both CaP and BPH specimens. However, a statistically significant increase in the frequency and the expression levels was observed in the specimens of the CaP patients compared to the specimens of BPH patients. Additionally, in the subset of patients with CaP, a statistically significant correlation between the DDC mRNA levels, the tumor stage and the tumor grade was documented. It seems that higher DDC expression levels are correlated with advanced stages and higher Gleason scores. These results, in clinical practice, imply poor prognosis and the need for implementation of the best possible therapy. In studying the prognostic value of DDC expression levels in CaP, we used as primary endpoint the disease-free survival (DFS), as long as from the patients with CaP who were followed no one died. As period of biochemical recurrence was considered the time elapsed from the day of radical prostatectomy to the measurement of two continuing values tPSA≥0.2 ng/ml. Fifty six patients were followed, with an average follow-up period of 28.6 ± 2.1 months, and median of 35.1 months. A statistically significant correlation between the DDC expression levels and the recurrence risk in the patients with CaP was established. From the logistic regression analysis, it is indicated that the expression of DDC gene, at mRNA level, constitutes an independent prognostic marker, with the DDC (+) patients with CaP having a significantly lower DFS compared to DDC (-) patients. CONCLUSIONS: The findings of this study support the key role of L-DOPA decarboxylase in the molecular pathogenesis of CaP, as it has been proposed from previous studies, while, at the same time, indicate a novel means that may cause a profound change in the diagnosis, prognosis and treatment of patients with CaP.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koutallelis, Georgios
- Κουταλέλλης, Γεώργιος
Subjects
dc:subject × 16- L-DOPA αποκαρβοξυλάση (DDC)
- Καρκίνος προστάτη
- Μοριακοί δείκτες
- Βιοχημική υποτροπή
- Ελεύθερη νόσου επιβίωσης
- Ριζική προστατεκτομή
- L-dopa decarboxylase
- Prostate cancer
- Molecular markers
- Biochemical recurrence
- Disease free survival ( DFS)
- Radical prostatectomy
- Ιατρική και Επιστήμες Υγείας
- Ιατρική Βιοτεχνολογία
- Medical and Health Sciences
- Medical Biotechnology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/27251